
Early Alzheimer’s Treatment Shows Promise, But Funding Uncertainty Looms
Millions of people have lost their identities and memories due to Alzheimer’s, which has been an unstoppable force for decades. Sue and a few other patients, however, may be living examples of how the disease’s course can be slowed down. Sue has been taking gantenerumab, an experimental medication, for more than ten years after being…